| Term | Definition |
|---|---|
| IM | Intramuscular |
| IMP | Imipenemase |
| iMPV | Inhaled murepavadin |
| IND | Investigational new drug |
| IPO | Initial Public Offering |
| IQWiG | Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen |
| ISV | Independent software vendor |
| ITT | Intent-to-treat |
| iv | Intravenous |
| JPIAMR | Joint Programming Initiative on AMR |
| K-res | Norwegian Centre for Detection of Antimicrobial Resistance |
| KOL | Key Opinion Leader |
| KPC | Klebsiella pneumoniae carbapenemase |
| LIMS | Laboratory Information Management System |
| LMICs | Low- and middle-income countries |
| LOI | Letter of Intent |
| LOS | Length of stay |
| LRE | Linezolid resistant enterococci |
| LVRE | Linezolid and vancomycin resistant enterococci |
| MAA | Marketing authorization application |
| mAb | Monoclonal antibody |
| MAD | Multiple ascending dose |
| MBL | Metallo-β-lactamase |
| MBO/MBI | Management buy-out, or buy-in |
| MDR | Multidrug-resistant |
| MDRO | Multi-drug-resistant organism |
| MIC | Minimum inhibitory concentration |
| micro-ITT | Microbiologic intent-to-treat |
| MITT | Modified intent-to-treat |
| MMDS | Model-based medical decision support |
| MOA | Mode of action |
| MRL | Maximum residue level |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| MRSP | Methicillin resistant Staphylococcus pseudintermedius |
| MSIS | Norwegian Surveillance System for Communicable Disease |
| MSSA | Methicillin-susceptible Staphylococcus aureus |
| MTF | Multilateral Trading Facility (‘stock exchange’) |
| MTV/HTA | Medicinsk teknologivurdering/Health Technology Assessment |
| MVP | Minimum Viable Product (rapid prototyping) |
| NBTI | Novel bacterial topoisomerase inhibitor |
| NCR | No known cross-resistance |
| NDA | New drug application |
| NDHRS | Norwegian Dairy Herd Recording System |
| NDM | New Delhi metallo-β-lactamase |
| NFSA | Norwegian Food Safety Authority |
| NHIN | Nationwide Health Information Network USA |
| NICE | National Institute of Clinical Excellence, UK body whose prime purpose it is to evaluate and disseminate best healthcare practices (its equivalent institute in Germany is called IQWiG) |
| NIPH | Norwegian Institute of Public Health |
| NIR | Danish National Infection-Hygiene Guidelines, which are a set of standards and best practices for infection control within the healthcare sector. These guidelines are used as a basis for quality control and audits to ensure proper hygiene and safety in hospitals and other healthcare facilities. |
| NNIS | National Nosocomial Infections Surveillance |